CC-90009
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CC-90009, covering 2024-05-31 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes [Phase 1]